Company Filing History:
Years Active: 2006
Title: Juan Gimenez: Innovator in Hepatitis B Vaccine Development
Introduction
Juan Gimenez is a notable inventor based in Lansdale, Pennsylvania, who has made significant contributions to the field of vaccine development. His work primarily focuses on improving the efficacy of vaccines against hepatitis B, a critical area in public health.
Latest Patents
Juan Gimenez holds a patent for the recombinant hepatitis B surface antigen (rHBsAg). This invention provides an improved rHBsAg that exhibits higher antigenicity and immunogenicity than previously known variants. The method of producing this enhanced rHBsAg is also detailed in the patent. The improved HBsAg is designed to create vaccines that require lower amounts of active ingredients while offering higher immunogenicity. Additionally, it supports the development of combination vaccines that provide protective immunization against hepatitis B virus and other infectious agents.
Career Highlights
Juan Gimenez is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has been instrumental in advancing vaccine technology and improving public health outcomes. His innovative approach to vaccine development has positioned him as a key figure in the field.
Collaborations
Juan has collaborated with esteemed colleagues such as Qinjian Zhao and Robert D. Sitrin. These partnerships have fostered a collaborative environment that enhances research and development efforts in vaccine technology.
Conclusion
Juan Gimenez is a pioneering inventor whose work in hepatitis B vaccine development has the potential to significantly impact public health. His innovative contributions continue to advance the field of immunology and vaccine research.